LENZ Therapeutics Revenue and Competitors

Location

#2563

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • LENZ Therapeutics's estimated annual revenue is currently $2.8M per year.(i)
  • LENZ Therapeutics's estimated revenue per employee is $100,500
  • LENZ Therapeutics's total funding is $50.4M.

Employee Data

  • LENZ Therapeutics has 28 Employees.(i)
  • LENZ Therapeutics grew their employee count by 56% last year.

LENZ Therapeutics's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
Head Commercial OperationsReveal Email/Phone
3
VP QualityReveal Email/Phone
4
VP FinanceReveal Email/Phone
5
VP SalesReveal Email/Phone
6
VP, Clinical OperationsReveal Email/Phone
7
VP, CMC and ManufacturingReveal Email/Phone
8
Senior Director, Marketing & Alliance ManagementReveal Email/Phone
9
Director Supply ChainReveal Email/Phone
10
Chief Commercial Officer (CCO)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is LENZ Therapeutics?

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors.

keywords:N/A

$50.4M

Total Funding

28

Number of Employees

$2.8M

Revenue (est)

56%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LENZ Therapeutics News

2022-04-20 - Global Myopia And Presbyopia Eye Drop Market Key Players ...

Orasis Pharmaceuticals; AbbVie Inc. Novartis AG; OSRX Pharmaceuticals; LENZ Therapeutics; Visus Therapeutics; Ocuphire Pharma Inc. Eyenovia,...

2022-04-17 - In Frank Clyburn's absence, Merck taps seasoned veteran to ...

... a licensing deal with LENZ Therapeutics for its two presbyopia candidates. ... The industry-wide effort to push CAR-T therapies — wildly...

2022-04-06 - LENZ Therapeutics and JIXING Announce an Exclusive ...

LENZ is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Its lead programs, LNZ100...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M2833%$18M
#2
$4.1M28N/AN/A
#3
$2M284%$8.9M
#4
$3.5M2847%$30.1M
#5
$3.6M28-3%N/A